Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Public comment period · §2

Draft synthesis: Bacterial endotoxin in research-supply… — submissions

The 2 submissions received, published in full with declared interests and secretariat responses.

Document identifier
CEI-CP-116/2
Series
Public comment period
Version
1.0
Published
10 Aug 2026
Last reviewed
10 Aug 2026
Next review
10 Aug 2027
Identifier
10.71829/cei.cp.116
Certainty
Not rated
Cycle
2026 Q3
Window
10 Aug 2026 – 05 Oct 2026
Status
Open
Submissions
2

§2Submissions and responses

2 submissions were received. Each is published in full below with its declared interest, the secretariat response and the disposition. The Institute publishes submissions it did not accept in the same form as those it did.

Dr Adaeze Underhill-Okafor, MD, MSc (Clinical Trials) University department of public health · submitting on evidence synthesis
DRAFT-ENDOTOXIN-IN/001 received 03 Sep 2026

The sampling frame of each contributing survey is not reported

The respondent’s comment on the draft review of What is known about bacterial endotoxin content in peptides supplied for research and injected in practice? arises from comparing the pooled figures against the reports they were taken from.

The included surveys each obtained material from a set of sources, and the draft reports what was found without reporting how the sources were chosen.

The respondent states that a survey that bought from the most visible sellers and a survey that bought at random from a directory answer different questions, and that pooling them without recording the difference produces a figure that describes neither.

The respondent proposes that the sampling frame, the number of sources approached and the number that supplied be tabulated for every contributing survey.

Declared interest. Has previously served as an investigator on a trial included in the evidence base under consultation. Received no personal payment; institutional payment was made to the trial site.
Secretariat responseAccepted15 Oct 2026

The secretariat accepts this submission. How material was obtained determines what a survey can support, and the draft treated the surveys as interchangeable.

Every contributing survey now carries a sampling row stating the frame, the number of sources approached and the number supplying, and the synthesis reports separately for surveys whose frames are not comparable.

Professor Bartolomeu Nkosi-Lindegaard, PhD Professor of Regulatory Science · submitting on regulatory science
DRAFT-ENDOTOXIN-IN/002 received 14 Sep 2026

Regulatory assessment documents were not searched

The respondent notes that the review question — What is known about bacterial endotoxin content in peptides supplied for research and injected in practice? — is answerable only if the contributing determinations measured the same quantity, and submits with that in view.

The respondent states that regulatory assessment reports frequently contain analyses that never appear in journals, and that a search limited to bibliographic databases will miss them.

The respondent proposes that regulatory documents be searched for every review in the series.

Declared interest. Is a member of the Institute's external reviewer register but did not review the document under consultation.
Secretariat responseAccepted in part01 Nov 2026

The secretariat accepts this submission in part. Regulatory assessment documents are searched. The proposal that they be treated as equivalent to a full study report is declined, because the level of detail varies and is often insufficient for risk-of-bias assessment.

Published regulatory assessment documents are now searched as a named source, are reported as a distinct evidence class in the included-studies table, and contribute to the assessment while being excluded from pooled estimates where risk of bias could not be assessed from the document.

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.